Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals.
Inflamm Bowel Dis
; 19(11): 2457-63, 2013 Oct.
Article
in En
| MEDLINE
| ID: mdl-23962896
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Crohn Disease
/
Integrin alpha4
/
Antibodies, Monoclonal, Humanized
/
Immunosuppressive Agents
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Inflamm Bowel Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2013
Document type:
Article
Country of publication:
United kingdom